Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Cooperberg

Showing results (491-500 of 522) with videos related to

Pageof 53
Sort By:
Prostate Cancer and Prostatic Diseases|June 10, 2021
Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline functionDaniel D Joyce, Christopher J D Wallis, Amy N Luckenbaugh, et al.
The Journal of Urology|January 3, 2022
Association between Treatment for Localized Prostate Cancer and Mental Health OutcomesAmy N Luckenbaugh, Christopher J D Wallis, Li-Ching Huang, et al.
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
Phase I Study of CTT1057, an <sup>18</sup>F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate CancerSpencer C Behr, Rahul Aggarwal, Henry F VanBrocklin, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasisHanbing Song, Junxiang Xu, Keila Velazquez-Arcelay, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.
Histopathology|June 3, 2024
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stageJane K Nguyen, Lara R Harik, Eric A Klein, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Pageof 53

Showing results (491-500 of 522) with videos related to

Sort By:
Pageof 53
Prostate Cancer and Prostatic Diseases|June 10, 2021
Sexual function outcomes of radiation and androgen deprivation therapy for localized prostate cancer in men with good baseline functionDaniel D Joyce, Christopher J D Wallis, Amy N Luckenbaugh, et al.
The Journal of Urology|January 3, 2022
Association between Treatment for Localized Prostate Cancer and Mental Health OutcomesAmy N Luckenbaugh, Christopher J D Wallis, Li-Ching Huang, et al.
Cancer|September 5, 2019
Real-world outcomes of sipuleucel-T treatment in PROCEED, a prospective registry of men with metastatic castration-resistant prostate cancerCelestia S Higano, Andrew J Armstrong, A Oliver Sartor, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 23, 2018
Phase I Study of CTT1057, an <sup>18</sup>F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate CancerSpencer C Behr, Rahul Aggarwal, Henry F VanBrocklin, et al.
JAMA Oncology|September 16, 2021
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging TrialThomas A Hope, Matthias Eiber, Wesley R Armstrong, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
A single-cell and spatial atlas of prostate cancer reveals the combinatorial nature of gene modules underlying lineage plasticity and metastasisHanbing Song, Junxiang Xu, Keila Velazquez-Arcelay, et al.
BMC Cancer|December 5, 2023
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative studyAlice Guan, Eduardo J Santiago-Rodríguez, Benjamin I Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2019
Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective StudiesWilliam C Jackson, Jessica Silva, Holly E Hartman, et al.
Histopathology|June 3, 2024
Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stageJane K Nguyen, Lara R Harik, Eric A Klein, et al.
Journal of the National Cancer Institute|October 16, 2018
The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic TargetShuang G Zhao, Jonathan Lehrer, S Laura Chang, et al.
Pageof 53